The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
ceftazidime · Powder
3 marketed package NDCs · 3 active manufacturers
Most dispensed: 1 g · Injection, Powder, For Solution · #25 vials/carton / 1 injection, powder, for solution in 1 vial
Same drug class
Other molecules FDA puts in Cephalosporin Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- cefotaxime· in shortage
- cefotaxime injection· in shortage
- ceftazidime, avibactam· 1 maker
- ceftobiprole medocaril sodium· 1 maker
- ceftolozane and tazobactam· 1 maker
- cefuroxime· 1 maker
- cefuroxime and dextrose· 1 maker
- zidebactam dihydrate and cefepime hydrochloride· 1 maker
- cefiderocol sulfate tosylate· 2 makers
- cefotetan· 2 makers
- cefotetan disodium· 2 makers
- ceftaroline fosamil· 2 makers
Common questions
- Is Ceftazidime in shortage right now?
- No. FDA does not currently list Ceftazidime in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ceftazidime?
- 6 companies have marketed Ceftazidime in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.